ISS Recommends Shareholders Vote 'FOR' Bristol-Myers Squibb (BMY)/Celgene (CELG) Deal

March 29, 2019 9:17 AM

(Updated - March 29, 2019 9:34 AM EDT)

In an e-mail to StreetInsider.com, Bristol-Myers Squibb (NYSE: BMY) confirmed that ISS recommended voting in favor of the Celgene (NASDAQ: CELG) deal.

Highlights from ISS

Categories

Analyst Comments Hot M&A Mergers and Acquisitions Trader Talk

Next Articles